Search results
Parkland Fuel shares retain buy rating, price target cut By Investing.com
Investing.com· 21 hours agoOn Tuesday, Parkland Fuel Corp (TSX:PKI:CN) (OTC: PKIUF) saw itsprice target adjusted by Canaccord...
National Bankshares Lowers Docebo (NASDAQ:DCBO) Price Target to $55.00
ETF DAILY NEWS· 6 hours agoA number of other research firms have also recently issued reports on DCBO. The Goldman Sachs Group cut their price target on Docebo ...
Think corporate greed is the leading cause of inflation? Think again | CNN Business
CNN.com· 49 minutes agoSome progressives have frequently blamed corporate greed for fueling the high cost of living that...
HSBC Cuts Zoetis (NYSE:ZTS) Price Target to $225.00
ETF DAILY NEWS· 4 days agoZoetis (NYSE:ZTS – Free Report) had its price target trimmed by HSBC from $230.00 to $225.00 in a report released on Wednesday, Benzinga reports. The brokerage ...
E.W. Scripps (NASDAQ:SSP) Price Target Cut to $4.50
ETF DAILY NEWS· 7 hours agoE.W. Scripps (NASDAQ:SSP – Get Free Report) had its price target lowered by equities research analysts at Wells Fargo & Company from $6.00 to $4.50 in a ...
Royal Bank of Canada Cuts JELD-WEN (NYSE:JELD) Price Target to $13.00
ETF DAILY NEWS· 4 days agoJELD-WEN (NYSE:JELD – Free Report) had its price target cut by Royal Bank of Canada from $16.00 to $13.00 in a research note released ...
Target Dropped Flattering Vacation Dresses to Round Out Your Summer Wardrobe Starting at $12
People via Yahoo News· 10 hours agoAnother reviewer said the dress “looks expensive” compared to its affordable price tag. Wild Fable...
Barclays Cuts Rockwell Automation (NYSE:ROK) Price Target to $260.00
ETF DAILY NEWS· 4 days agoRockwell Automation (NYSE:ROK – Free Report) had its target price trimmed by Barclays from $265.00 to $260.00 in a research report report published on Wednesday ...
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Price Target Cut to $40.00
ETF DAILY NEWS· 5 days agoprice objective cut by research analysts at HC Wainwright from $46.00 to $40.00 in a research note issued on Wednesday, Benzinga reports. HC Wainwright’ ...
The Goldman Sachs Group Lowers Revance Therapeutics (NASDAQ:RVNC) Price Target to $8.00
ETF DAILY NEWS· 6 hours agoRevance Therapeutics (NASDAQ:RVNC – Get Free Report) had its price target reduced by analysts at The Goldman Sachs Group from $9.00 to $8.00 in a report ...